Chimeric antigen receptor (CAR) T-cell therapy uses your own modified T-cells to target and fight cancer cells. This referral-based type of cancer treatment is approved by the Food and Drug Administration (FDA) to treat certain blood cancers such as B-cell lymphoma or acute lymphoblastic leukemia.
Did you know?
Oncologists see cellular therapy as a breakthrough cancer treatment with tremendous potential. Besides CAR T-cells, other therapies involve CAR-NK and TILs. Learn More
CAR T-cell therapy works by collecting your blood, separating the T-cells off and returning the other parts of your blood. These T-cells are then altered in a lab to include special proteins (CARs). The engineered cells are infused back into your body to empower your immune system.
Accredited Provider of CAR T-cell Therapy
Avera Cancer Institute is proud to provide cutting-edge cellular therapy treatments. Accredited by the Foundation for the Accreditation of Cellular Therapies (FACT), Avera serves as the only health system in the region with the expertise to perform this treatment.
How CAR T-cell Therapy Works
- Blood cells removed.
- CAR T-cells collected and sent to lab.
- CAR T-cells manufactured to include proteins (chimeric antigen receptors).
- CAR T-cells are infused back into the body.
- Chimeric antigen receptors help T-cells find and kill cancer cells.
